CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	APIC	Accumulated Deficit	Noncontrolling Interest	Common Class A Common Stock	Common Class B Common Stock
Balance, at beginning of period (in shares) at Dec. 31, 2022					2,900,000	11,278,000
Balance, at beginning of period at Dec. 31, 2022	$ 5,595	$ 2,611	$ (344)	$ 3,314	$ 3	$ 11
Stock-based compensation	706	706
Issuance related to vesting of restricted stock units, net of tax withholdings (in shares)					90,092
Warrants exercised (in shares)					70,801
Warrants exercised	122	122
Stock options exercised (in shares)					7,883
Stock options exercised	29	29
Conversion of Class B shares to Class A common stock (in shares)					410,000	(410,000)
Conversion of Class B to Class A Common Stock	0	145		(145)
Acquisition and redemption of warrants, including expenses and related items	(3,540)	(3,540)
Additional paid-in capital related to tax receivable agreement	250	250
Distributions to holders of LLC Units	(1,737)			(1,737)
Net loss	(6,844)		(2,194)	(4,650)
Noncontrolling interest rebalancing	0	2,744		(2,744)
Balance, at end of period (in shares) at Dec. 31, 2023					3,478,776	10,868,000
Balance, at end of period at Dec. 31, 2023	(5,419)	3,067	(2,538)	(5,962)	$ 3	$ 11
Stock-based compensation	1,552	1,552
Issuance related to vesting of restricted stock units, net of tax withholdings (in shares)					207,681
Issuance related to vesting of restricted stock units, net of tax withholdings	(327)	(328)			$ 1
Warrants exercised (in shares)					39,101
Warrants exercised	215	215
Stock options exercised (in shares)					12,557
Stock options exercised	92	92
Issuance of stock in lieu of cash bonus, net of tax withholdings ( in shares )					69,677
Issuance of stock in lieu of cash bonus, net of tax withholdings	906	906
Commitment shares issued in connection with th equity reserve facility ( in shares )					62,762
Commitment shares issued in connection with the Equity Reserve Facility	150	150
Issuance pursuant tothe Equity Reserve Facility, net of issuance costs ( in shares )					1,580,000
Issuance pursuant to the Equity Reserve Facility	3,008	3,006			$ 2
Net loss	(19,907)		(6,236)	(13,671)
Noncontrolling interest rebalancing	0	(4,891)		4,891
Balance, at end of period (in shares) at Dec. 31, 2024					5,450,554	10,868,000
Balance, at end of period at Dec. 31, 2024	$ (19,730)	$ 3,769	$ (8,774)	$ (14,742)	$ 6	$ 11